DIVY

MELBOURNE: The failure of Opthea’s much-heralded eye treatment has already caused considerable pain ... read more

MELBOURNE: ResMed shares jump 7.5 per cent to a two-week high of $35.66 ... read more

MELBOURNE: Listed pharma giant Telix has seen its shares sink on Monday after ... read more

MELBOURNE: The Australian sharemarket has lifted as investors drove a rally in banks, ... read more